Telogen effluvium. New possibilities of correction


如何引用文章

全文:

详细

The current understanding of the causes and trigger points, classification, clinical picture, diagnosis and new approaches to the treatment of telogen effluvium are presented. The data of the clinical study of 60 patients with telogen effluvium, developed on the background of iron deficiency anemia, a comparative characteristic of Fe2+salts therapy vs combination therapy with Fe2+salts with topical lotion Qilib are described.

作者简介

Tamara Berechikidze

I.M. Sechenov First Moscow State Medical University

Email: Berechikidze@inbox.ru
MD, PhD, asisstent of Department of Skin and Venereal Diseases of I.M. Setchenov First Moscow State Medical University Moscow, 119991, Russian Federation

V. Pinegin

I.M. Sechenov First Moscow State Medical University

Кафедра и клиника кожных и венерических болезней им. В.А. Рахманова лечебного факультета Moscow, 119991, Russian Federation

参考

  1. Trueb R.M. Hair growth and disorders. In: Blume-Peytavi U., Tosti A., Whiting D.A., Trueb R., eds. Diffuse hair loss. Berlin: Springer; 2008: 259-72.
  2. Trueb R.M. Female Alopecia. Guide to Successful Management. Springer, 2013.
  3. Dawber R.P.R. Hair and Scalp Diseases: Medical, Surgical, and Cosmetic Treatments (Basic and Clinical Dermatology).Wiley; 1997: 107-9.
  4. Олисова О.Ю., Верхогляд И.В., Гостроверхова И.П. Современное представление об этиологии, патогенезе и лечении очаговой алопеции Российский журнал кожных и венерических болезней. 2010; 1: 48-52.
  5. Корнишева В.Г., Ежков Г.А., Патология волос и кожи волосистой части головы. СПб.: Фолиант; 2012.
  6. Shashikant M. Telogen effluvium: a review. J. Clin. Diagn. Res. 2015; 9(9): 1-3.
  7. Костюкевич О.И. Современные подходы к диагностике и лечению синдрома кахексии с позиции врача-терапевта. Российский медицинский журнал. 2011; 1: 24-6.
  8. Min S.K., Chul W.K. Analysis of serum zinc and copper concentrations in hair loss. Ann. Dermatol. 2013; 25(4): 405-9.
  9. Фитцпатрик Т., Джонсон Р., Вульф К., Полано М., Сюрмонд Д. Дерматология. Атлас-справочник. Пер. с англ. М.: Практика; 2007.
  10. Калинченко С.Ю., Пигарова Е.А., Гусакова Д.А., Плещеева А.В. Витамин D и мочекаменная болезнь. Consilium Medicum. 2012; 12: 97-102.
  11. Chen T.C., Chimeh F., Lu Z., Mathieu J., Person K.S., Zhang A., Kohn N., Martinello S., Berkowitz R., Holick M.F. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch. Biochem. Biophys. 2007; 460(2): 213-7.
  12. van den Bergh J.P., Bours S.P., van Geel T.A. Geusens P.P. Optimal use of vitamin D when treating osteoporosis. Curr. Osteoporos Rep. 2011; 9(1): 36-42. doi: 10.1007/s11914-010-0041-0.
  13. Chen T.C., Lu Z., Holick M.F. Photobiology of vitamin D. In: Holick M.F., ed. Vitamin D: Physiology, Molecular Biology, and Clinical Applications. Springer; 2010.
  14. Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin Endocrinol. Metab. 1988; 67(2): 373-8.
  15. Peterlik M., Boonen S., Cross H.S., Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int. J. Environ. Res. Public Health. 2009; 6(10): 2585-607. doi: 10.3390/ijerph6102585.
  16. Pittas A. G., Lau J., Hu F., Dawson-Hughes B. Vitamin D and calcium intake in relation to type 2 diabetes in women. J. Clin. Endocrinol. Metab. 2007; 92(6): 2017-29.
  17. Krause R., Bühring M., Hopfenmüller W., Holick M.F., Sharma A.M. Ultraviolet B and blood pressure. Lancet. 1998; 352(9129): 709-10.
  18. Белая Ж.Е., Рожинская Л.Я. Витамин D в терапии остеопороза: его роль в комбинации с препаратами для лечения остеопороза, внескелетные эффекты. Эффективная фармакотерапия. Эндокринология. Спецвыпуск. .2013; 2(38): 14-29.
  19. Rasheed H., Mahgoub D., Hegazy R., El-Komy M., Abdel Hay R., Hamid M.A., Hamdy E. Serum ferritin and vitamin D in female hair loss: do they play a role? Skin Pharmacol. Physiol. 2013; 26(2): 101-7. doi: 10.1159/000346698.
  20. WHO global database on anaemia. Geneva: WHO; 2008. http://www.who.int/vmnis/anaemia/en/
  21. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001. (WHO/NHD/01.3). http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.
  22. Casoli A. Amana Cellium CG 210 clinical efficacy by phototrichogram on alopecia male patients. Clinical Study Report. АСЕРА 3, France, Martillac: Institut Dermatologique d’Aquitaine (IDEA); 2007. http://www.surgicalcosmetic.org.
  23. Takeda A., Sato A., Zhang L., Harti S., Cauwenbergh G., Liu J., CG210 enables Finasteride 1 mg users to further improve hair pattern. Hair Ther. Transplant. 2013; 3: 1. http://www.omicsgroup.org/journals/cg-enables-finasteride-mg-users-tofurther-improve-hair-pattern-a-randomized-doubleblind-placebocontrolledpilot-study-2167-0951.1000107.pdf
  24. Cucé L.C., Rodrigues C.J., Patriota C.R. Clinical efficacy by biopsies on alopecia male patients - 4 months. CEBA 4 Clinical report No. “CEBA 4”. Universidade de Santo Amaro (São Paulo). Brasil, 2004. http://www.surgicalcosmetic.org.
  25. Cucé L.C., Rodrigues C.J., Patriota R.C. Cellium® GC: evaluation of a new natural active ingredient in 210 mg/ml topical solution, through scalp biopsy. Surg. Cosmet. Dermatol. 2011; 3(2): 123-8.

版权所有 © Eco-Vector, 2016


 


##common.cookie##